April 24 (Reuters) - Biogen beat Wall Street estimates for first-quarter profit on Wednesday, helped by a series of cost-cutting measures as older drugs face fierce competition. The company also said its Alzheimer's drug Leqembi, developed with Japanese partner Eisai ( ESALF ), recorded global sales of about $19 million, nearly tripling from the fourth quarter of 2023. The number...

April 24 (Reuters) - Humana beat first-quarter profit expectations on Wednesday, helped by strength in its government-backed Medicare Advantage insurance business for older adults. On an adjusted basis, Humana reported a profit of $7.23 per share, higher than the average analyst estimate of $6.12 per share, according to LSEG data. (Reporting by Mariam Sunny and Leroy Leo in Bengaluru; Editing...

06:46 AM EDT, 04/24/2024 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) reported fiscal Q1 adjusted earnings Wednesday of $5.11 per diluted share, up from $5.03 a year earlier. Analysts polled by Capital IQ expected $4.71. Revenue for the quarter ended March 30 was $10.34 billion, down from $10.71 billion a year earlier. Analysts surveyed by Capital IQ expected...

(Reuters) -Hasbro ( HAS ) reported a smaller-than-expected drop in first-quarter sales and easily beat profit estimates on Wednesday, as leaner inventories and steady digital gaming revenue helped cushion a drag from softer demand for toys. Shares of the company, up roughly 14% this year, rose about 4% in premarket trading. The Play-Doh maker has grappled with weakening demand over...